What Researchers Did
Scientists tested whether adding hyperbaric oxygen to antibiotic treatment could improve killing of Pseudomonas aeruginosa bacteria from cystic fibrosis patients, using a lab model of bacterial clusters.
What They Found
This laboratory study found that hyperbaric oxygen treatment significantly increased the ability of the antibiotic tobramycin to kill Pseudomonas aeruginosa bacterial aggregates from all the cystic fibrosis patient isolates tested. The bacteria were grown embedded in agarose gel to mimic the low-oxygen clusters seen in chronically infected lungs. The researchers attributed this improved killing to increased oxygenation of the bacterial aggregates. The abstract does not report specific numerical figures such as percentages or fold-changes for this effect.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This was an in vitro laboratory study using an artificial bacterial aggregate model, not a clinical trial in cystic fibrosis patients, so it does not show whether hyperbaric oxygen would improve outcomes in real patients.